<p>(A) Cells were treated with 0, 0.9, 1.8, and 2.7μM RY10-4 for 24 h, and the DNA content was analyzed using propidium iodide staining and flow cytometry. (B) Cell cycle distributions, presented as mean ± SD of three independent experiments. (C) After the treatment with RY10-4, expression of cell cycle-related proteins cyclin E and CDK2 was analyzed by Western blot.</p
<p>Both cell lines were transfected and/or exposed to 10 μM OXA for 8, 24, 48 and 72 h. After propid...
<p>Cells treated with vehicle (DMSO) or indicated concentration of hesperidin were collected and ass...
<p>(<b>A</b>). DNA content (propidium iodide) and cell cycle analysis of EF24-treated cells. The fiv...
<p>(A) Cells were treated with indicated concentrations of RY10-4 for 24 h, and the nuclei were stai...
<p>(A) HepG2 cells were treated with indicated concentrations of RY10-4, and the intracellular ROS p...
<p>A. The cell cycle distribution of treated HepG2 cells. B. Contents of each phase of HepG2 cells t...
<p>HepG2 cells were treated with 100 µM of fatty acid esters of phloridzin (Pz), pz or phloretin or ...
<p>COS7 cells were treated with FC101 (0–5 µM) for 24 h. The cells were then harvested and processed...
<p>HepG2 cells were treated with the (<b>A</b>) indicated doses of ribavirin (0∼100 µg/ml) for 24 h,...
<p>Cells were incubated 48β-HB (0, 0.6, 1.2, 2.4 or 4.8 mM) in serum-free medium. A) Cell cycle anal...
<p>(A) Representative flow cytometry analysis of DNA contents (PI staining) in WEHI-3 cells after 24...
<p>MCF-7 cells (left) and LN229 cells (right) were left untreated (top) or treated with the indicate...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
The values indicated the percentage of cells in the indicated phases of the cell cycle. The data sho...
<p>MCF-7 cells were treated with <b>PNAP</b>-<b>1</b>, -<b>3h</b>, and -<b>6h</b> at three concentra...
<p>Both cell lines were transfected and/or exposed to 10 μM OXA for 8, 24, 48 and 72 h. After propid...
<p>Cells treated with vehicle (DMSO) or indicated concentration of hesperidin were collected and ass...
<p>(<b>A</b>). DNA content (propidium iodide) and cell cycle analysis of EF24-treated cells. The fiv...
<p>(A) Cells were treated with indicated concentrations of RY10-4 for 24 h, and the nuclei were stai...
<p>(A) HepG2 cells were treated with indicated concentrations of RY10-4, and the intracellular ROS p...
<p>A. The cell cycle distribution of treated HepG2 cells. B. Contents of each phase of HepG2 cells t...
<p>HepG2 cells were treated with 100 µM of fatty acid esters of phloridzin (Pz), pz or phloretin or ...
<p>COS7 cells were treated with FC101 (0–5 µM) for 24 h. The cells were then harvested and processed...
<p>HepG2 cells were treated with the (<b>A</b>) indicated doses of ribavirin (0∼100 µg/ml) for 24 h,...
<p>Cells were incubated 48β-HB (0, 0.6, 1.2, 2.4 or 4.8 mM) in serum-free medium. A) Cell cycle anal...
<p>(A) Representative flow cytometry analysis of DNA contents (PI staining) in WEHI-3 cells after 24...
<p>MCF-7 cells (left) and LN229 cells (right) were left untreated (top) or treated with the indicate...
<p>(<b>A–D</b>) BV173 and K562 cells were treated with the indicated concentration of HP-β-CyD for 1...
The values indicated the percentage of cells in the indicated phases of the cell cycle. The data sho...
<p>MCF-7 cells were treated with <b>PNAP</b>-<b>1</b>, -<b>3h</b>, and -<b>6h</b> at three concentra...
<p>Both cell lines were transfected and/or exposed to 10 μM OXA for 8, 24, 48 and 72 h. After propid...
<p>Cells treated with vehicle (DMSO) or indicated concentration of hesperidin were collected and ass...
<p>(<b>A</b>). DNA content (propidium iodide) and cell cycle analysis of EF24-treated cells. The fiv...